一例由[病因不明]引起的皮肤真菌病重症病例在接种新冠疫苗后病情加重，必须与脓疱型银屑病相鉴别。 （注：原文中“-caused”部分缺失具体病因信息）
A severe case of -caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis.
作者信息
Norimatsu Yuta, Norimatsu Yurie
机构信息
Department of Dermatology, University of Tokyo Graduate School of Medicine, 113-8655, 7-3-1,Hongo, Bunkyo-ku, Tokyo, Japan.
Department of Dermatology, Ageo Daiichi Clinic for Internal Medicine and Pediatrics, 362-0064, 845-1 Koshikidani, Ageo, Saitama, Japan.
出版信息
Med Mycol Case Rep. 2022 Mar 12;36:19-22. doi: 10.1016/j.mmcr.2022.03.001. eCollection 2022 Jun.
We present a case of deep dermatomycosis caused by that developed after administration of SARS-CoV-2 BNT162b2 vaccination. A 75-year-old man was vaccinated with SARS-CoV-2 on day 0 and day 23. From day 25, pustules began to appear. A skin biopsy was performed. Tissue culture revealed the presence of . The patient was treated with topical luliconazole and 100 mg/day oral fosravuconazole for 84 days, after which the symptoms resolved.
我们报告了1例接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）BNT162b2疫苗后发生的由[具体病菌未提及]引起的深部皮肤真菌病病例。一名75岁男性在第0天和第23天接种了SARS-CoV-2疫苗。从第25天起开始出现脓疱。进行了皮肤活检。组织培养显示存在[具体病菌未提及]。该患者接受了外用卢立康唑和每日100毫克口服伏沙康唑治疗84天，之后症状缓解。
Zotero 插件